OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 91 filers reported holding OVID THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $54,192 | +35.3% | 16,522 | +6.4% | 0.02% | +30.8% |
Q1 2023 | $40,047 | +38.7% | 15,522 | 0.0% | 0.01% | +30.0% |
Q4 2022 | $28,871 | -0.4% | 15,522 | 0.0% | 0.01% | +100.0% |
Q3 2022 | $29,000 | -40.8% | 15,522 | 0.0% | 0.01% | -44.4% |
Q1 2022 | $49,000 | -2.0% | 15,522 | 0.0% | 0.01% | -40.0% |
Q4 2021 | $50,000 | -3.8% | 15,522 | 0.0% | 0.02% | 0.0% |
Q3 2021 | $52,000 | -29.7% | 15,522 | -16.2% | 0.02% | -44.4% |
Q1 2021 | $74,000 | – | 18,522 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWH Capital, L.P. | 230,000 | $407,000 | 0.69% |
BVF INC/IL | 3,293,000 | $5,829,000 | 0.65% |
COWEN INC. | 1,101,414 | $1,950,000 | 0.21% |
ARMISTICE CAPITAL, LLC | 1,780,000 | $3,151,000 | 0.17% |
Granite Point Capital Management, L.P. | 417,857 | $740,000 | 0.07% |
Redmile Group, LLC | 737,550 | $1,305,000 | 0.04% |
Tekla Capital Management LLC | 496,977 | $880,000 | 0.04% |
Fairpointe Capital LLC | 101,000 | $179,000 | 0.01% |
Alyeska Investment Group, L.P. | 225,000 | $398,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,440 | $149,000 | 0.00% |